Radioreceptor assays offer the advantage of a single assay that can assess
uniform exposure to multiple chemical compounds. The advent of atypical ant
ipsychotic agents has led to new awareness of the multiple receptor subtype
s through which antipsychotic agents may exert their effects, and a renewed
interest in comparative drug trials of antipsychotics. The objective of th
is study was to show the development and validation of antipsychotic radior
eceptor assays using clonal cell lines stably expressing isolated human rec
eptors. Model assays were developed using the dopamine(2) (D-2) and D-4 rec
eptors. D-2 and D-4 activities measured by radioreceptor assay in plasma of
antipsychotic-treated subjects were highly correlated with highperformance
liquid chromatography determinations of antipsychotic concentrations. Simi
larly, for a variety of typical and atypical antipsychotic agents, the quot
ients of D-4/D-2 activity in plasma of antipsychotic-treated subjects were
highly correlated with the quotients of D-4/D-2 affinities of these agents.
Valid receptor-selective antipsychotic assays can be established and may h
ave utility for dissecting the in vivo activity of atypical antipsychotics
in relation to specific outcomes in clinical trials.